atazanavir sulfate has been researched along with AIDS Seroconversion in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 9 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldin, G; Belmonti, S; Borghetti, A; Ciccullo, A; De Luca, A; Di Giambenedetto, S; Emiliozzi, A; Gagliardini, R; Lamonica, S; Lombardi, F; Montagnani, F; Moschese, D; Visconti, E | 1 |
Atrio, J; Cherala, G; DuBois, BN; Stanczyk, FZ | 1 |
Abgrall, S; Bucher, H; Cain, LE; Caniglia, EC; Casabona, J; Costagliola, D; Dabis, F; Esteve, A; Fehr, J; Hernán, MA; Jarrín, I; Jose, S; Justice, A; Logan, R; Meyer, L; Muga, R; Olson, A; Paparizos, V; Pérez-Hoyos, S; Phillips, A; Reiss, P; Robins, J; Rubio, R; Sabin, C; Seng, R; Sterne, JAC; Tate, J; Touloumi, G; van Sighem, A; Vandenhende, MA | 1 |
Beniowski, M; De Wit, S; Gatell, J; Kirk, O; Ledergerber, B; Lundgren, JD; Mocroft, A; Phillips, AN; Reiss, P; Sedlacek, D | 1 |
Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; Di Perri, G; Gonzalez de Requena, D; Siccardi, M; Simiele, M; Tettoni, M; Trentini, L | 1 |
Ananthakrishnan, S; Garg, A; Levine, D | 1 |
Aubry, C; Badens, C; Javelle, E; Oliver, M; Savini, H; Simon, F | 1 |
Bower, M; Dunning, J; Manley, K; Nelson, M | 1 |
Carman, T; Hileman, C; Labbato, DE; Longenecker, C; McComsey, G; Milne, G; Storer, Nj; White, C | 1 |
Bassetti, D; Castagna, A; De Pascalis, CR; Fusetti, G; Galli, A; Gianotti, N; Guffanti, M; Lazzarin, A; Seminari, E | 1 |
Acinapura, R; Antinori, A; Liuzzi, G; Marconi, P; Sette, P; Trotta, MP; Zaccarelli, M; Zinzi, D | 1 |
Coleman, CI; White, CM | 1 |
1 trial(s) available for atazanavir sulfate and AIDS Seroconversion
Article | Year |
---|---|
Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.
Topics: Adolescent; Adult; Atazanavir Sulfate; Contraceptives, Oral, Synthetic; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; HIV Protease Inhibitors; HIV Seropositivity; Humans; Metabolic Clearance Rate; Norethindrone; Oligopeptides; Progestins; Pyridines; Radioimmunoassay; Ritonavir; Up-Regulation; Young Adult | 2015 |
11 other study(ies) available for atazanavir sulfate and AIDS Seroconversion
Article | Year |
---|---|
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Ritonavir; Tenofovir; Treatment Outcome; Viral Load | 2019 |
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.
Topics: Adult; Alkynes; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; United States; Viral Load | 2016 |
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Disease Progression; Epidemiologic Methods; Female; Glomerular Filtration Rate; HIV Seropositivity; HIV-1; Humans; Indinavir; Kidney Failure, Chronic; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir | 2010 |
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2011 |
Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy.
Topics: Adenine; Adrenal Insufficiency; Adult; Atazanavir Sulfate; Cushing Syndrome; Cytochrome P-450 Enzyme Inhibitors; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Iatrogenic Disease; Injections, Intramuscular; Lamivudine; Oligopeptides; Organophosphonates; Pruritus; Pyridines; Ritonavir; Tenofovir; Triamcinolone Acetonide | 2011 |
Severe atazanavir-associated hyperbilirubinemia revealing Canton G6PD deficiency in an Asian HIV-infected patient.
Topics: Adult; Anti-HIV Agents; Asian People; Atazanavir Sulfate; Gilbert Disease; Glucosephosphate Dehydrogenase Deficiency; HIV Seropositivity; Humans; Hyperbilirubinemia; Male; Oligopeptides; Pyridines | 2012 |
HIV-associated gastric natural killer/T-cell lymphoma.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Atazanavir Sulfate; Cyclophosphamide; Doxorubicin; Female; HIV Seropositivity; Humans; Lamivudine; Lymphoma, Extranodal NK-T-Cell; Oligopeptides; Prednisone; Pyridines; Pyrrolidinones; Raltegravir Potassium; Stomach Neoplasms; Vincristine | 2012 |
Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy.
Topics: Adult; Atazanavir Sulfate; Bilirubin; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Cell Adhesion Molecules; Cross-Sectional Studies; Endothelium, Vascular; F2-Isoprostanes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; HIV Protease Inhibitors; HIV Seropositivity; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Oligopeptides; Oxidative Stress; Pyridines; Retrospective Studies; Tumor Necrosis Factor-alpha; Vasodilation | 2012 |
Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.
Topics: Adult; Atazanavir Sulfate; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Female; Furans; HIV Protease Inhibitors; HIV Seropositivity; Humans; Male; Middle Aged; Oligopeptides; Pilot Projects; Pyridines; Reverse Transcriptase Inhibitors; Sulfonamides; Treatment Outcome | 2003 |
Lipodystrophy is associated with a low rate of treatment failure in HIV-positive patients switched to atazanavir.
Topics: Atazanavir Sulfate; HIV Seropositivity; HIV-Associated Lipodystrophy Syndrome; Humans; Oligopeptides; Pyridines; Switzerland; Treatment Failure; Treatment Refusal | 2005 |
A comparison of different protease inhibitors on coronary heart disease risk.
Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Clinical Trials as Topic; Coronary Disease; HIV Protease Inhibitors; HIV Seropositivity; Humans; Hyperlipidemias; Nelfinavir; Oligopeptides; Pyridines; Risk Factors | 2007 |